NDC 68071-4963-01 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-4963
- Requested NDC
- 68071-4963-01
- Package NDCs from labels
- 68071-4963-9, 68071-4963-1, 68071-4963-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2025-06-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only | NuCare Pharmaceuticals,Inc. | 2025-06-27 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2023-02-02 | HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only |
| 2023-01-30 | HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only |
| 2021-02-18 | HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only |
| 2021-01-29 | HYDROCHLOROTHIAZIDE TABLETS USP 2083 2089 Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4963-1 | Hydrochlorothiazide | 20 in 1 BOTTLE | TABLET | 20 | 6 | |
| 68071-4963-9 | Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET | 90 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4963 | HYDROCHLOROTHIAZIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250105_8d5a9196-5f1d-2d83-e053-2a95a90a6036.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | 973973a3-9fec-4afc-910f-187f099dfe2d | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 1a04bf47-07fb-ed32-e063-6294a90a07cc | 2024-06-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 6a11a458-dc69-40ba-a58a-649733e0e8ab | 2024-05-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 447c11b6-72fe-418e-a2db-5d90b5347796 | 2024-05-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 2b66693d-0514-4f41-b405-bd3dd7618e81 | 2024-05-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Bryant Ranch Prepack | 02eb8f54-789e-4148-912b-601d23a7df4a | 2024-05-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 4c74bc01-1065-79f0-f9c4-044ead38a55d | 2024-05-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Amlodipine, Valsartan and Hydrochlorothiazide | AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 6fba5243-ee00-4825-a04a-321cb6b49c56 | 2024-05-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 36fbc5fc-4a75-4aa3-bed1-78944135ae11 | 2024-05-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1884db5f-72b5-6b0c-e063-6394a90a0e49 | 2024-05-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1bb08103-04ee-47a6-a9ad-290e169feb51 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | c8740506-c679-4c41-a96a-8ddbcddd72c6 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | abf2fe45-8b69-4d3c-981e-289c0aa3e98b | 2024-05-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | c6ed6f74-0eca-4f99-8c7e-dd3f56167f01 | 2024-05-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Fosinopril Sodium and Hydrochlorothiazide | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 35019655-9a30-4305-a262-936ad0e73071 | 2024-04-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE | QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 50a58159-9572-4445-9859-b392632597da | 2024-04-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 98a58b54-bcf2-4726-800a-facf48d9155f | 2024-04-25 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | cba87d5b-9302-7b2c-e053-2a95a90a7f9d | 2024-04-17 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 39d4dbd3-8f24-4898-a240-e94e06fa229a | 2024-04-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 4c0b028d-f0f4-417f-a068-dca24e56113f | 2024-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.